Search Results - "PIRSON, Yves"

Autosomal dominant polycystic kidney disease by Torres, Vicente E, MD, Harris, Peter C, PhD, Pirson, Yves, MD

“…Summary Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial…”
Get full text

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference by Chapman, Arlene B, Devuyst, Olivier, Eckardt, Kai-Uwe, Gansevoort, Ron T, Harris, Tess, Horie, Shigeo, Kasiske, Bertram L, Odland, Dwight, Pei, York, Perrone, Ronald D, Pirson, Yves, Schrier, Robert W, Torra, Roser, Torres, Vicente E, Watnick, Terry, Wheeler, David C

“…Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals and is the fourth most common cause for renal replacement therapy…”
Get more information

Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1 by Olinger, Eric, Hofmann, Patrick, Kidd, Kendrah, Dufour, Inès, Belge, Hendrica, Schaeffer, Céline, Kipp, Anne, Bonny, Olivier, Deltas, Constantinos, Demoulin, Nathalie, Fehr, Thomas, Fuster, Daniel G, Gale, Daniel P, Goffin, Eric, Hodaňová, Kateřina, Huynh-Do, Uyen, Kistler, Andreas, Morelle, Johann, Papagregoriou, Gregory, Pirson, Yves, Sandford, Richard, Sayer, John A, Torra, Roser, Venzin, Christina, Venzin, Reto, Vogt, Bruno, Živná, Martina, Greka, Anna, Dahan, Karin, Rampoldi, Luca, Kmoch, Stanislav, Bleyer, Sr, Anthony J, Devuyst, Olivier

“…Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an increasingly recognized cause of end-stage kidney disease, primarily due to mutations in…”
Get more information

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy by Gross, Oliver, Licht, Christoph, Anders, Hans J, Hoppe, Bernd, Beck, Bodo, Tönshoff, Burkhard, Höcker, Britta, Wygoda, Simone, Ehrich, Jochen H H, Pape, Lars, Konrad, Martin, Rascher, Wolfgang, Dötsch, Jörg, Müller-Wiefel, Dirk E, Hoyer, Peter, Knebelmann, Bertrand, Pirson, Yves, Grunfeld, Jean-Pierre, Niaudet, Patrick, Cochat, Pierre, Heidet, Laurence, Lebbah, Said, Torra, Roser, Friede, Tim, Lange, Katharina, Müller, Gerhard A, Weber, Manfred

“…Alport syndrome inevitably leads to end-stage renal disease and there are no therapies known to improve outcome. Here we determined whether…”
Get more information

Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations by Temme, Johanna, Peters, Frederick, Lange, Katharina, Pirson, Yves, Heidet, Laurence, Torra, Roser, Grunfeld, Jean-Pierre, Weber, Manfred, Licht, Christoph, Müller, Gerhard-Anton, Gross, Oliver

“…We studied here the clinical course of heterozygous carriers of X-linked Alport syndrome and a subgroup of patients with thin basement membrane disease due to…”
Get more information

Complement activation and effect of eculizumab in scleroderma renal crisis by Devresse, Arnaud, Aydin, Selda, Le Quintrec, Moglie, Demoulin, Nathalie, Stordeur, Patrick, Lambert, Catherine, Gastoldi, Sara, Pirson, Yves, Jadoul, Michel, Morelle, Johann

“…Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis characterized by abrupt onset of hypertension, thrombotic…”
Get full text

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice by Terryn, Wim, Cochat, Pierre, Froissart, Roseline, Ortiz, Alberto, Pirson, Yves, Poppe, Bruce, Serra, Andreas, Van Biesen, Wim, Vanholder, Raymond, Wanner, Christoph

“…Fabry disease (FD) is an X-linked disorder of glycosphingolipid catabolism resulting in the accumulation of glycolipids including globotriaosylceramide in…”
Get full text

Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome by Belge, Hendrica, Dahan, Karin, Cambier, Jean-François, Benoit, Valérie, Morelle, Johann, Bloch, Julie, Vanhille, Philippe, Pirson, Yves, Demoulin, Nathalie

“…Hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome is a rare autosomal dominant disorder, secondary to mutations in the GATA-3 gene. Due to its…”
Get full text

Positron-Emission Computed Tomography in Cyst Infection Diagnosis in Patients with Autosomal Dominant Polycystic Kidney Disease by Jouret, François, Lhommel, Renaud, Beguin, Claire, Devuyst, Olivier, Pirson, Yves, Hassoun, Ziad, Kanaan, Nada

“…Cyst infection remains a challenging issue in patients with autosomal dominant polycystic kidney disease (ADPKD). In most patients, conventional imaging…”
Get full text

Phenotype and Outcome in Hereditary Tubulointerstitial Nephritis Secondary to UMOD Mutations by Bollée, Guillaume, Dahan, Karin, Flamant, Martin, Morinière, Vincent, Pawtowski, Audrey, Heidet, Laurence, Lacombe, Didier, Devuyst, Olivier, Pirson, Yves, Antignac, Corinne, Knebelmann, Bertrand

“…UMOD mutations cause familial juvenile hyperuricemic nephropathy (FJHN) and medullary cystic kidney disease (MCKD), although these phenotypes are nonspecific…”
Get full text

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance by Guitard, Joëlle, Hebral, Anne-Laure, Fakhouri, Fadi, Joly, Dominique, Daugas, Eric, Rivalan, Joseph, Guigonis, Vincent, Ducret, Françis, Presne, Claire, Pirson, Yves, Hourmant, Maryvonne, Glachant, Jean-Claude, Vendrely, Benoit, Moranne, Olivier, Faguer, Stanislas, Chauveau, Dominique

“…Minimal-change nephrotic syndrome (MCNS) is a common cause of steroid sensitive nephrotic syndrome (NS) with frequent relapse. Although steroids and…”
Get full text

Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease by Pirson, Yves

“…Although asymptomatic in most patients, extrarenal manifestations of ADPKD may become more clinically relevant with the increasing life expectancy of affected…”
Get full text

Mutations in Human Complement Regulator, Membrane Cofactor Protein (CD46), Predispose to Development of Familial Hemolytic Uremic Syndrome by Richards, Anna, Kemp, Elizabeth J., Liszewski, M. Kathryn, Goodship, Judith A., Lampe, Anne K., Decorte, Ronny, Müslümanoǧglu, M. Hamza, Kavukcu, Salih, Filler, Guido, Pirson, Yves, Wen, Leana S., Atkinson, John P., Timothy H. J. Goodship

“…Membrane cofactor protein (MCP; CD46) is a widely expressed transmembrane complement regulator. Like factor H it inhibits complement activation by regulating…”
Get full text

Atypical haemolytic uraemic syndrome associated with a hybrid complement gene by Venables, Julian P, Strain, Lisa, Routledge, Danny, Bourn, David, Powell, Helen M, Warwicker, Paul, Diaz-Torres, Martha L, Sampson, Anne, Mead, Paul, Webb, Michelle, Pirson, Yves, Jackson, Michael S, Hughes, Anne, Wood, Katrina M, Goodship, Judith A, Goodship, Timothy H J

“…Sequence analysis of the regulators of complement activation (RCA) cluster of genes at chromosome position 1q32 shows evidence of several large genomic…”
Get full text

Association of PKD2 (Polycystin 2) Mutations With Left-Right Laterality Defects by Bataille, Stanislas, MD, Demoulin, Nathalie, MD, Devuyst, Olivier, MD, PhD, Audrézet, Marie-Pierre, PhD, Dahan, Karin, MD, PhD, Godin, Michel, MD, PhD, Fontès, Michel, PhD, Pirson, Yves, MD, Burtey, Stéphane, MD, PhD

“…Mutations in the PKD1 (polycystin 1) and PKD2 (polycystin 2) genes cause autosomal dominant polycystic kidney disease (ADPKD). Most Pkd2 -null mouse embryos…”
Get full text

Carbohydrate Antigen 19-9 as a Diagnostic Marker for Hepatic Cyst Infection in Autosomal Dominant Polycystic Kidney Disease by Kanaan, Nada, MD, Goffin, Eric, MD, Pirson, Yves, MD, Devuyst, Olivier, MD, PhD, Hassoun, Ziad, MD

“…The diagnosis of hepatic cyst infection is difficult in patients with autosomal dominant polycystic kidney disease (ADPKD). We hypothesized that carbohydrate…”
Get full text

Mutations in SEC63 cause autosomal dominant polycystic liver disease by Somlo, Stefan, Davila, Sonia, Furu, Laszlo, Gharavi, Ali G, Tian, Xin, Onoe, Tamehito, Qian, Qi, Li, Airong, Cai, Yiqiang, Kamath, Patrick S, King, Bernard F, Azurmendi, Pablo J, Tahvanainen, Pia, Kääriäinen, Helena, Höckerstedt, Krister, Devuyst, Olivier, Pirson, Yves, Martin, Rodolfo S, Lifton, Richard P, Tahvanainen, Esa, Torres, Vicente E

“…Mutations in PRKCSH, encoding the β-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum (ER), cause autosomal dominant…”
Get full text

Recurrence and Graft Loss after Kidney Transplantation for Henoch–Schönlein Purpura Nephritis: A Multicenter Analysis by Kanaan, Nada, Mourad, Georges, Thervet, Eric, Peeters, Patrick, Hourmant, Maryvonne, Vanrenterghem, Yves, De Meyer, Martine, Mourad, Michel, Maréchal, Céline, Goffin, Eric, Pirson, Yves

“…The actuarial risk at 5 years for clinical recurrence of Henoch-Schönlein purpura nephritis (HSPN) and graft loss caused by recurrence of -HSPN after renal…”
Get full text

Genotype and Outcome After Kidney Transplantation in Alport Syndrome by Gillion, Valentine, Dahan, Karin, Cosyns, Jean-Pierre, Hilbert, Pascale, Jadoul, Michel, Goffin, Eric, Godefroid, Nathalie, De Meyer, Martine, Mourad, Michel, Pirson, Yves, Kanaan, Nada

“…Alport syndrome (AS) is caused by mutations in α3/α4/α5 (IV) collagen genes, the severity of which determine the progression of AS. Posttransplantation outcome…”
Get full text

Comparison between siblings and twins supports a role for modifier genes in ADPKD by Persu, Alexandre, Duyme, Michel, Pirson, Yves, Lens, Xosé M., Messiaen, Thierry, Breuning, Martijn H., Chauveau, Dominique, Levy, Micheline, Grünfeld, Jean-Pierre, Devuyst, Olivier

“…Comparison between siblings and twins supports a role for modifier genes in ADPKD. Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by…”
Get full text